CRISPR-Cas9-based treatment of myocilin-associated glaucoma [Genetics]

Primary open-angle glaucoma (POAG) is a leading cause of irreversible vision loss worldwide, with elevated intraocular pressure (IOP) a major risk factor. Myocilin (MYOC) dominant gain-of-function mutations have been reported in ∼4% of POAG cases. MYOC mutations result in protein misfolding, leading to endoplasmic reticulum (ER) stress in the trabecular...

from Genetics via xlomafota13 on Inoreader http://ift.tt/2ggHhyD
via IFTTT